The oncogenic kinase AKT1 is frequently overexpressed or activated in sporadic breast and ovarian cancers. In human breast tumors, we have previously shown that AKT1 represses homologous recombination (HR) induced by one double-strand break (DSB). To further analyze the impact of AKT1 on HR, we ectopically expressed wildtype or mutant forms of AKT1 in a hamster ovary cell line containing an intrachromosomal substrate for monitoring HR. In this cell line, AKT1 repressed HR induced by different genotoxic stresses including ionizing radiation, UV-C and one single DSB introduced into the intrachromosomal substrate. Consistently, AKT1 disrupted RAD51 foci formation, showing that AKT1 specifically affects gene conversion. Concomitantly, AKT1 represses both BRCA1 foci formation and HR stimulation resulting from BRCA1 overexpression, showing that AKT1 affects BRCA1-mediated HR functions, also in another species (hamster) and in another type of cell tissue (ovary cells). Finally, consistent with the HR defects, active AKT1 expression induces supernumerary centrosomes and aneuploidy. In addition to its impact on cell proliferation and apoptosis, the present data propose a novel oncogenic function for AKT1, by producing genomic instability as a consequence of HR repression.
Introduction
Familial breast and ovary cancers are generally caused by mutations in genes involved in DNA damage responses, with mutations in the BRCA1 and BRCA2 genes being the most common hereditary mutations (Venkitaraman, 2002; Narod and Foulkes, 2004) . However, most of breast and ovarian cancers are sporadic nonhereditary cases. The oncogenic kinase AKT1 was found overexpressed in 38-60% of sporadic breast or ovary cancers (Sun et al., 2001; Yang et al., 2006) . The AKT1 pathway negatively regulates the level of BRCA1 mRNA, and reciprocally BRCA1 deficiency was recently shown to activate the AKT oncogenic pathway (Xiang et al., 2008) . Moreover, AKT1 also regulates BRCA1 on a posttranslational level, as it is able to phosphorylate BRCA1 in vitro and promotes the nuclear translocation of BRCA1 in T47D human breast cancer cells (Altiok et al., 1999; Miralem and Avraham, 2003; Hinton et al., 2007) . In contrast, in human fibroblasts and breast cancer cells, we have recently shown that AKT1 activation results in the cytoplasmic retention of BRCA1 and inhibition of homologous recombination (HR) induced by a double-strand break (DSB) targeted into the HR substrate (Plo et al., 2008) . Importantly, cytoplasmic retention of BRCA1 was strongly correlated with the level of AKT1 activation in sporadic primary breast tumors (Plo et al., 2008) .
HR is an evolutionary conserved process that contributes to the variability/stability balance of the genome. Although HR is necessary to maintain genomic stability, excess HR can also generate genetic diversity. Consequently, a very precise regulation of HR is required to maintain the equilibrium between stability and diversification of the genome while avoiding genetic instability. Specifically, HR-defective cells (particularly BRCA1-defective cells) exhibit multipolar mitotic cells and aneuploidy, although the underlying molecular mechanisms remain to be elucidated (Lee et al., 1999; Griffin et al., 2000; Deng, 2002; Kraakman-van der Zwet et al., 2002; Bertrand et al., 2003; Hut et al., 2003; Daboussi et al., 2005) . Thus, if AKT1 actually represses HR, it should also produce centrosomal defects that contribute to the genetic instability of AKT1-activated cells. Before addressing this question, it was first essential to test whether the AKT1-mediated HR repression was a general process by addressing the question in another mammalian species and after induction by different genotoxic stresses. Moreover, because AKT1 is activated in a high frequency of sporadic ovarian cancers (Sun et al., 2001; Yang et al., 2006) , it was thus essential to test the impact of AKT1 on HR also in ovarian cells.
To address these questions, we expressed wild-type and mutant forms of AKT1 in engineered Chinese hamster ovary cells, the CHO-DRA10 cell line. These CHO cells contain one single copy of an intrachromosomal substrate for monitoring HR. We then measured the impact of AKT1 not only on HR induced by various stresses, that is, ionizing radiation (IR), UV-C or by a DSB targeted into the HR substrate, but also on the formation of RAD51 (the pivotal HR protein) foci. We also verified the impact of AKT1 on BRCA1 foci formation, and HR stimulation induced by BRCA1, in the hamster ovary cells. Finally, we analyzed the impact of AKT1 expression on the production of supernumerary centrosomes at mitosis and on the ploidy.
Results and discussion
CHO-DRA10 is a CHO cell line containing a single copy of an intrachromosomal substrate for HR (Liang et al., 1998) . This substrate can monitor multiple pathways (single-strand annealing, gene conversion), but can be tailored to specifically monitor gene conversion with the use of different antibiotics (Supplementary data S1A). We derived several CHO-DRA10 clones stably expressing the wild-type (wtAKT1), the membrane-targeted active (myrAKT1) or a kinase-dead (kdAKT1) form of AKT1 (Supplementary data S1B). AKT1 requires membrane targeting for activation of its kinase activity. Expression of HA-tagged active wtAKT1 and myrAKT1 was detected mostly at the membrane ( Figure 1a ). In contrast, the labeling of the inactive kdAKT1, which contains a mutation in the domain required for membrane targeting, was more diffuse (Figure 1a ). AKT1 kinase activity can be assayed by detecting autophosphorylation with phospho-specific antibodies (anti-[pS 473 ] AKT or anti- [pT 308 ] AKT). Basal AKT1 kinase activity was undetectable in the parental CHO-DRA10 cell line (Figure 1b ). WtAKT1 and myrAKT1 cell lines both exhibited efficient AKT1 phosphorylation activity whereas no detectable AKT1 phosphorylation was observed in the kdAKT1 cell lines (Figure 1b) . Importantly, the level of exogenous active AKT1 in our CHO-derived cell lines was comparable to the level of endogenous AKT1 measured in the MCF7 cell line or in breast tumor samples ( Figure 1c ).
As expected, IR-and UV-C-stimulated HR in the CHO-DRA10 cell line (Wang et al., 1988; Saintigny et al., 1999; Lambert and Lopez, 2000; Lambert and Lopez, 2002) (Figures 2a-b) . Expression of active wtAKT1 or myrAKT1 abrogated the IR-and UV-Cinduced HR, resulting in a dramatic decrease in the frequency of induced recombinants (Neo R cells) in clones expressing the two active AKT1 forms, compared to the parental cell line (Figures 2a-b) . In contrast, the inactive kdAKT1 failed to repress HR induction by IR or UV-C.
We then investigated the effect of AKT1 on HR stimulation at a unique DSB introduced by exposure to the rare-cutting meganuclease I-SceI (Liang et al., 1998) . We monitored Neo R /Hyg R double-resistant clones, which are produced by gene conversion events (see Supplementary data S1). Active wtAKT1 and myr-AKT1 both systematically reduced the frequency of double-resistant clones (Neo R /Hyg R ), whereas inactive kdAKT1 had no effect ( Figure 2c ). These results show that AKT1 specifically inhibits gene conversion.
Genotoxic stress causes the HR protein RAD51 to assemble into nuclear foci, as can be seen in IR-treated CHO-DRA10 cells (Haaf et al., 1995; Aten et al., 2004; Figure 2d ). The presence of active wtAKT1 or myrAKT1 inhibited the formation of IR-induced RAD51 foci (Figure 2d ), consistent with the repression of HR by AKT1. It is noteworthy that the level of RAD51 expression was not significantly affected by ]-AKT-specific antibodies (Cell Signaling Technology, Danvers, MA, USA). (c) After western blot analysis, the mean ratio of phosphorylated AKT to actin (P-AKT/actin) in AKT-overexpressing CHO clones, tumors (breast cancers) and MCF-7 cells. These ratios were calculated by quantification of the bands by densitometry using Image J software. The ratios are not significantly different.
overexpression of AKT1 (Supplementary data S2). Importantly, expression of kdAKT1 did not induce any change in RAD51 foci formation when compared to the parental cells (Figure 2d ). Because IR-induced RAD51 foci formation is cell-cycle dependent, we analyzed the cell-cycle distribution of irradiated cells by flow cytometry (Saintigny et al., 2007 ; Supplementary data S3). We did not observe any significant differences in the cell-cycle distributions of the different clones up to 24 h after exposure to 6 Gy IR (Supplementary data S3) . Hence, the inhibition of RAD51 foci formation at late time points appears to be linked directly to a defect in HR regulation itself, rather than to the loss of a damage checkpoint or to RAD51 expression. Gene conversion and IR-or UV-C-induced single Neo R events are all RAD51-dependent processes (Ivanov et al., 1996; Lambert and Lopez, 2000; Lambert and Lopez, 2002) . Altogether, the present results show that AKT1 kinase activity specifically affects the RAD51-dependent gene conversion pathway induced in hamster ovary cells exposed to different types of genotoxic stress.
We have shown that AKT1 promotes cytoplasmic retention of both endogenous and overexpressed exogenous BRCA1, in human fibroblasts or breast cancer cells (Plo et al., 2008) . Therefore, we investigated whether overexpression of AKT1 can also affect endogenous BRCA1 foci formation induced by IR. After transient expression of AKT1, coimmunostaining with anti-BRCA1 and anti-AKT1 antibodies showed that in a given culture, cells expressing AKT1 failed to assemble BRCA1 foci after IR, whereas endogenous I-SceI-induced recombination: 5 Â 10 5 cells were plated and transfected using JetPEI reagent (Q-Biogene, MP Biomedicals, Illkirch, France) with 10 mg of an expression vector for the I-SceI endonuclease (pCMV I-SceI). At 24 h after transfection, G418 and hygromycin were added. (d) IR-induced RAD51 foci (6 Gy). RAD51 foci were analyzed as described using an anti-RAD51 (1:100; Pharmingen, BD Bioscience, San Jose, CA, USA) antibody (Haaf et al., 1995) . Histograms: impact of AKT1 overexpression on the percentage of cells with RAD51 foci 12 h after IR exposure. At least 200 cells were counted per experiment. Results are reported as means±the standard error of the mean (s.e.m.) for at least three independent experiments. Statistical significance (Po0.05) is indicated by an asterisk (*) using the Student's t-test.
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BRCA1 assembled into foci in cells lacking AKT1 expression. Expression of kdAKT1 did not inhibit IR-induced BRCA1 foci formation (Figure 3a-b) . Stable expression of AKT1 also impaired IR-induced BRCA1 foci (Figure 3c ).
To more specifically analyze the impact of AKT1 on BRCA1 functions, we then further checked the impact of AKT1 on exogenous BRCA1 in the hamster ovary cells used here. BRCA1 has different localization patterns in CHO compared to human SV40-transformed fibroblasts, that is, nuclear and cytoplasmic, respectively (Figure 4a, and Plo et al., 2008) . These results were confirmed with two different anti-BRCA1 antibodies, raised against the N or C terminus (data not shown). This cell-line-specific difference in BRCA1 localization could be due to the amount of BARD1, a protein that binds to and regulates BRCA1 nuclear shuttling. Western blot analysis showed that the endogenous levels of both BRCA1 and BARD1 proteins are undetectable in human RG37 fibroblasts relative to CHO and MCF7 human breast cancer cells (Supplementary data S4). It is possible that overexpression of exogenous BRCA1 protein overwhelms the nuclear import machinery in low BARD1-expressing cells, such , were irradiated at 6 Gy and cells with endogenous BRCA1 foci formation were shown at 6 h. BRCA1 (red) and AKT1 (green) were visualized by coimmunostaining. Histograms: percentage of cells with endogenous BRCA1 foci. (b) CHO-DRA10 clones, stably expressing wild type, myrAKT1 or kdAKT1, were irradiated at 6 Gy and the percentage of cells with endogenous BRCA1 foci formation was measured at various times. AKT expression and BRCA1 foci were analyzed using an anti-AKT (1:100; Cell Signaling) and anti-BRCA1 (1:100, Ab-1; Oncogene, VWR, Fontenay-sous-bois, France) antibodies as described by Haaf et al. (1995) . At least 200 cells were counted per experiment. The percentage of cells was reported as means±s.e.m. Statistical significance (Po0.05) is indicated by an asterisk (*) using the Student's t-test.
as human RG37 fibroblasts, but not in high BARD1-expressing cells, such as CHO cells. Importantly, overexpression of AKT1 leads to a cytoplasmic localization of BRCA1 also in hamster ovary cells (Figure 4a ). To more directly assess the function of AKT1 on BRCA1 in HR, we analyzed the effect of BRCA1 overexpression on I-SceI-induced HR in CHO-DRA10 cells. As previously described in human fibroblasts (Zhang et al., 2004) , co-transfection of I-SceI and BRCA1 led to a twofold stimulation of HR (Figure 4b ). This strategy allowed us to focus specifically on BRCA1-controlled HR and, thus, the impact of AKT1 on this specific pathway. We co-transfected BRCA1 and I-SceI with AKT1 and measured the frequency of induced recombinants (Neo R cells) (Figure 4b ). WtAKT1 abrogated BRCA1-stimulated HR. These results show that AKT1 negatively regulates HR stimulated by BRCA1 in another species (hamster) and another type of cell line (ovary cells).
In vertebrate cells, defective HR can result in genomic instability and increased mutagenesis (Liu et al., 1998; Sonoda et al., 1998; Griffin et al., 2000; Takata et al., 2001; Lambert and Lopez, 2002; Bertrand et al., 2003; Deans et al., 2003) . Particularly, high frequency of multipolar cells at mitosis commonly results from disruption of HR by interfering with the functions of BRCA1 as well as RAD51, BRCA2 or the RAD51 paralogs XRCC2 and XRCC3, (Lee et al., 1998; Xu et al., 1999; Griffin et al., 2000; Bertrand et al., 2003; Daboussi et al., 2005) . Multipolar cells lead to aberrant chromosome segregation and aneuploidy, a hallmark of tumor cells. Because AKT1 affects HR, it would also be expected to affect centrosome function. Therefore, we measured the impact of AKT1 overexpression on the number of centrosomes at mitosis (Figures 5a and b) . Consistent with HR repression and BRCA1 mislocalization, active wtAKT1 and myrAKT1 cells showed a higher frequency of cells displaying abnormal number of centrosomes compared to the parental CHO-DRA10 cells and to kdAKT1-overexpressing CHO clones (Figure 5b ). These results show that AKT1 activation induces supernumerary centrosomes at mitosis. Because centrosome defects should lead to aneuploidy, we measured cell ploidy. As shown in Figure 5c , a significant increased number of aneuploid cells was seen in AKT1-overexpressing clones as compared to the parental cell line. These results show that active AKT1 can result in centrosome and chromosome segregation abnormalities.
In summary, we propose an underlying molecular mechanism for the development of AKT1-associated sporadic cancers whereby overactive AKT1 represses HR, and induces centrosome and chromosome segregation abnormalities, which should lead to genetic instability. Our results also imply that BRCA1 malfunction has a function in AKT1-associated sporadic cancers, resulting in a brca1-defective phenotype and HR repression, without requiring BRCA1 mutation. with I-SceI (0.5 mg) and empty pcDNA3puro plasmids, or with I-SceI and AKT1 plasmids, in the presence or absence of the BRCA1 expression plasmid, with a DNA ratio of 1:3:3. In all cases, equal total amounts of DNA were used for each co-transfection. Induced homologous recombination (HR) was monitored by calculating the frequency of Neo R clones. Results are reported as means±s.e.m. for three independent experiments. Statistical significance (Po0.05) is indicated by an asterisk (*) using the Student's t-test.
The oncogenic potential of AKT1 is generally attributed to its ability to inhibit apoptosis, promote cell-cycle progression and regulate gene transcription. Genetic instability is a hallmark of cancer cells, implicated in both tumoral initiation and progression. Therefore, the data presented here suggest an additional The percentage of cells with extra centrosomes (>2) was measured in AKT1-overexpressing CHO clones. At least 200 cells in metaphase were counted and statistically analyzed using w 2 -tests. The asterisk represents significant differences (Po0.05) relative to the control. Active wtAKT1 and myrAKT1 cells showed a higher frequency of multipolar cells relative to controls. (c) The ploidy of the different cell lines was analyzed. Cells were incubated with colchicine (50 mg/ml) for 2 h, collected and incubated in KCl (12.5 mm) for 20 min at 37 1C. Cells were fixed overnight in methanol/acetic acid (3:1 v/v), washed three times in methanol/acetic acid, spread on cold microscope slides and stained with 3% Giemsa in 1.5% phosphate buffer (pH 6.7). At least 50 metaphases per cell line were analyzed and a nonparametric analysis of variance (ANOVA) was used for statistical significance of the distribution. Significant difference (Po0.05) was found in AKT1-overexpressing CHO clones compared to CHO-DRA10 or kdAKT1-overexpressing CHO clone. oncogenic potential of AKT1, resulting from HR repression (after variety of genotoxic stresses) and chromosome segregation defects, which leads to genetic instability.
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